Neurocrine Biosciences (NBIX) P/FCF US GAAP (year values) |
|||||||||
| 2021 | 2022 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| P/FCF | 34.6 | 35.4 | 35.6 | 24.6 | 18.8 | 19.2 | |||
| Changes by years, y/y, % | -16% | +3% | +0% | -31% | -23% | -14.4% | |||
Neurocrine Biosciences. P/FCF
Neurocrine Biosciences. P/FCF, changes, %
Neurocrine Biosciences (NBIX) P/FCF US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | LTM ? | |||
| P/FCF | 22.4 | 23.5 | 23.5 | 18.8 | 15.9 | 19.2 | ||
| Changes by years, y/y, % | +0% | -16% | -11% | -23% | -29% | |||
| Changes by quarters, q/q, % | -9% | +5% | 0% | -20% | -16% | |||